Thalassemia

• FDA approval · 2023-09-26
  FDA Approved: DEFERASIROX — Supplemental Application (Bionpharma Inc.)

  FDA approved a supplemental application for Deferasirox from Bionpharma Inc. under an ANDA, authorizing an additional regulatory action for …

• FDA approval · 2021-11-30
  FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)

  FDA approved a supplemental application for Ferriprox (deferiprone) submitted by Chiesi USA, Inc.

• FDA approval · 2018-04-20
  FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)

  The FDA approved a supplemental application for Ferriprox (deferiprone) filed by Chiesi USA, Inc., resulting in updated labeling for iron ch…